However, the CNS of chronic granulomatous disease (CGD) patients, who lack NOX2 activity, and NOX2 knock-out animal models, develop with only mild cognitive deficits (Kishida et al., 2006). The gene discussed is CYBB; the disease is chronic granulomatous disease.